文献速递心胸血管麻醉

心脏麻醉的麻醉选择偏好:心血管麻醉医师协会调查

Anesthetic Preferences for Cardiac Anesthesia: A Survey of the Society of Cardiovascular Anesthesiologists.
PubMed 文献 · Anesth Analg · 2022-07-11

该调查向心血管麻醉医师协会成员发放邮件问卷,共689人(21%)回应,旨在了解体外循环心脏手术中各阶段麻醉药偏好及理由。结果显示诱导期最常用丙泊酚(80%),预转机、转机和转机后阶段最常选七氟烷外的异氟烷(57%、62%、50%),易用性是主要理由,多数认为麻醉药有器官保护作用且影响患者结局。

要点

  • 诱导期最常用丙泊酚(80%),转机前后维持最常用异氟烷(50%-62%)。
  • 选择挥发性麻醉药的主要理由是易用性,转机期间其次为机构惯例。
  • 73%认为麻醉药有器官保护作用,72%认为麻醉选择影响患者结局。

核心结论

  • 多数受访心脏麻醉医师偏好挥发性麻醉药用于维持,认为麻醉选择影响患者结局且挥发性麻醉药具有器官保护特性。
  • 偏好这些药物的理由可能反映易用性、有效性和机构惯例等实际考虑也影响麻醉选择。

研究设计与样本

  • 向心血管麻醉医师协会成员发送电子邮件邀请的问卷调查,两次发送分别覆盖3328名和3274名成员,共689名(21%)回应。
  • 受访者中位年龄45岁(IQR 37-56),79%为男性,75%完成专科培训。

主要发现

  • 诱导期最常选择丙泊酚(80%)。
  • 预转机期最常选择异氟烷(57%),其次七氟烷(30%)。
  • 转机期最常选择异氟烷(62%),其次七氟烷(17%),第三丙泊酚(14%)。
  • 转机后期最常选择异氟烷(50%),其次七氟烷(24%),第三丙泊酚(17%)。
  • 76%受访者表示转机期间麻醉药通常由灌注师给予。

关键数值与推荐

  • 各阶段选择异氟烷和七氟烷的最常见理由是易用性。
  • 转机期间选择异氟烷和七氟烷的第二常见理由是机构惯例。
  • 缺血预处理、器官保护和术后认知功能较少被选为偏好挥发性麻醉药的理由。
  • 73%认为麻醉药具有器官保护特性,其中异氟烷74%、七氟烷59%。
  • 72%认为麻醉选择对患者结局有贡献;对「吸入麻醉药是心脏手术最佳维持麻醉药」的同意度中位数为72(IQR 63-85,0=强烈不同意至100=强烈同意)。

临床怎么用

  • 调查反映当前心脏麻醉实践中挥发性麻醉药(尤其异氟烷)在维持期占主导,诱导期丙泊酚常用。
  • 临床选择可能受易用性和机构惯例等实际因素影响,而不仅基于器官保护证据。

局限性

  • 回应率21%,可能存在无回应偏倚。
  • 调查结果基于受访者自我报告,非临床实践直接观察。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Volatile anesthetics have been historically preferred for cardiac anesthesia, but the evidence for their superiority to intravenous agents is mixed. We conducted a survey to better understand the current state of practice and the rationale behind provider preferences for anesthesia for cardiac surgery with cardiopulmonary bypass. We hypothesized that anesthetic preference would vary considerably among surveyed providers without a clear majority, as would the rationale behind those preferences. METHODS: Email invitations were sent to members of the Society of Cardiovascular Anesthesiologists, who were asked to identify the anesthetics or sedatives they typically prefer to administer during induction, prebypass, bypass, postbypass, and postoperative periods and why they prefer those agents. Members' beliefs regarding the importance of anesthetics on postoperative outcomes were also assessed. RESULTS: Invitations were sent on 2 separate dates to 3328 and 3274 members, of whom 689 (21%) responded. The median (interquartile range [IQR]) respondent age was 45 (37-56) years, 79% were men, and 75% were fellowship trained. The most frequently chosen drug for induction was propofol (80%). Isoflurane was the most frequently selected primary agent for the prebypass (57%), bypass (62%), and postbypass periods (50%). Sevoflurane was the second most frequently selected (30%; 17%, and 24%, respectively). Propofol was the third most frequently selected agent for the bypass (14%) and postbypass periods (17%). Ease of use was the most frequently selected reason for administering isoflurane and sevoflurane for each period. During bypass, the second most frequently selected rationale for using isoflurane and sevoflurane was institutional practice. A total of 76% responded that the perfusionist typically delivers the bypass anesthetic. Ischemic preconditioning, organ protection, and postoperative cognitive function were infrequently selected as rationales for preferring the volatile anesthetics. Most respondents (73%) think that anesthetics have organ-protective properties, especially isoflurane (74%) and sevoflurane (59%), and 72% believed that anesthetic choice contributes to patient outcome. The median (IQR) agreement (0 = strongly disagree to 100 = strongly agree) was 72 (63-85) for the statement that "inhaled anesthetics are an optimal maintenance anesthetic for cardiac surgery." CONCLUSIONS: In a survey of cardiac anesthesiologists, a majority of respondents indicated that they prefer volatile anesthetics for maintenance of anesthesia, that anesthetic selection impacts patient outcomes, and that volatile anesthetics have organ-protective properties. The members' rationales for preferring these agents possibly reflect that practical considerations, such as ease of use, effectiveness, and institutional practice, also influence anesthetic selection during cardiac surgery in addition to considerations such as organ protection.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. O'Gara BP, Beydoun NY, Mueller A, et al. Anesthetic Preferences for Cardiac Anesthesia: A Survey of the Society of Cardiovascular Anesthesiologists. Anesth Analg. 2022. PMID: 35819157. doi:10.1213/ANE.0000000000006147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。